Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 92

Sort by

Sort Order Select

Journal Articles

A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial

Blood (2018) 132 (Supplement 1): 467.

https://doi.org/10.1182/blood-2018-99-111756

Published: 2018

Journal Articles

Incidence and Prevalence of Light Chain Amyloidosis: A Population-Based Study

Suzanne Duhamel, MD, Dania Mohty, MD PhD, Julien Magne, PhD, David Lavergne, PhD, Dominique Bordessoule, MD, Victor Aboyans, MD PhD, Arnaud Jaccard

Blood (2017) 130 (Supplement 1): 5577.

https://doi.org/10.1182/blood.V130.Suppl_1.5577.5577

Published: 2017

Journal Articles

Efficacy of Eculizumab in Gemcitabine-Induced Thrombotic Microangiopathy: Experience of the French Thrombotic Microangiopathies Reference Centre

Maximilien Grall, MD, Francois Provôt, MD, Jean-Philippe Coindre, MD, Claire Pouteil-Noble, MD PhD, Dominique Guerrot, MD PhD, Ygal Benhamou, MD, Dominique Bordessoule, MD PhD, Agnes Veyradier, MD PhD, Paul Coppo, MD PhD, Steven Grange, MD

Blood (2016) 128 (22): 136.

https://doi.org/10.1182/blood.V128.22.136.136

Published: 2016

Journal Articles

Thrombotic Thrombocytopenic Purpura Misdiagnosed As Autoimmune Cytopenia: Causes of Diagnostic Errors and Consequence on Outcome. Experience of the French Thrombotic Microangiopathies Reference Centre

Maximilien Grall, MD, Ygal Benhamou, MD, Elie Azoulay, MD PhD, Eric Mariotte, MD, Lionel Galicier, MD, Steven Grange, MD, Virginie Barbay, MD, Dominique Bordessoule, MD PhD, Agnes Veyradier, MD PhD, Paul Coppo, MD PhD

Blood (2016) 128 (22): 3730.

https://doi.org/10.1182/blood.V128.22.3730.3730

Published: 2016

Journal Articles

Is Arsenic Trioxide (ATO) Required in the Treatment of High Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL2006) By the French Belgian Swiss APL Group

Blood (2016) 128 (22): 895.

https://doi.org/10.1182/blood.V128.22.895.895

Published: 2016

Journal Articles

Arsenic Trioxide (ATO) and ATRA with Limited Chemotherapy (CT) in Newly Diagnosed Standard Risk APL in the Elderly. a Report By the French Belgian Swiss APL Group (APL 2006 trial)

Lionel Ades, MD PhD, Xavier Thomas, MD PhD, Agnès Guerci, MD PhD, Arnaud Pigneux, MD, Norbert Vey, Emmanuel Raffoux, MD, Sylvie Castaigne, MD PhD, Olivier Spertini, Dominique Bron, MD PhD, Jean Pierre Marolleau, MD PhD, Gandhi Damaj, MD, Dominique Bordessoule, MD PhD, Julie Lejeune, Sylvie Chevret, Pierre Fenaux, MD PhD

Blood (2016) 128 (22): 898.

https://doi.org/10.1182/blood.V128.22.898.898

Published: 2016

Journal Articles

Correlation Between Bone Marrow Dysplasia and Genomic Profile in De Novo Acute Myeloid Leukemia (AML): A Study By the ALFA Group

Thomas Cluzeau, MDPhD, Orianne Wagner-Ballon, Thomas Boyer, Estelle Guerin, Emmanuel Benayoun, Daniel Lusina, Isabelle Garcia, Claude Gardin, Pierre Fenaux, MD PhD, Cecile Pautas, Bruno Quesnel, MD PhD, Dominique Bordessoule, Christine Terré, Xavier Thomas, MD PhD, Sylvie Castaigne, Aline Renneville, Claude Preudhomme, Herve Dombret, MD

Blood (2015) 126 (23): 2568.

https://doi.org/10.1182/blood.V126.23.2568.2568

Published: 2015

Journal Articles

Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group

Blood (2015) 126 (23): 451.

https://doi.org/10.1182/blood.V126.23.451.451

Published: 2015

Journal Articles

Very Good Response and Overall Survival after Allogeneic Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis; Results of a Non-Interventional Study By the Plasma Cell Disorder Subcommittee of the Chronic Malignancy Working Party of the EBMT

Stefan Schönland, Ute Hegenbart, MD, Simona Iacobelli, Jennifer Hoek, Jakob R. Passweg, MD, Dominique Bordessoule, Jean-Henri Bourhis, MD PhD, Martin R. Schipperus, MD PhD, Theo deWitte, Laurent Garderet, MD, Nicolaus Kröger

Blood (2015) 126 (23): 4397.

https://doi.org/10.1182/blood.V126.23.4397.4397

Published: 2015

Journal Articles

Outcome of Lower Risk Non Del 5q MDS after Failure of Erythropoiesis Stimulating Agents (ESA), and Impact of Post-ESA Treatment on Survival: A Retrospective European Study

Blood (2015) 126 (23): 1665.

https://doi.org/10.1182/blood.V126.23.1665.1665

Published: 2015

Journal Articles

Impact of Rituximab-Based Immunochemotherapy Induction and Maintenance on the Immunisation Rate Against Tetanus Toxin in Follicular Lymphoma Treated Patients : A Subanalysis of the PRIMA Study

Lionel Karlin, Jacques Bienvenu, PhD, Rene-Olivier Casasnovas, MD, Marie-Helene Delfau-Larue, MD PhD, Pierre Feugier, MD PhD, Jehan Dupuis, MD, Tioka Rabeony, Christophe Ferme, MD, Catherine Sebban, MD, Pierre Soubeyran, MD PhD, Guillaume Cartron, MD, Alain Delmer, MD PhD, Dominique Bordessoule, MD, Pauline Brice, MD, Thierry Lamy, MD PhD, Sami Bousseta, Hervé Tilly, MD PhD, Gilles Andre Salles, MD PhD

Blood (2014) 124 (21): 4430.

https://doi.org/10.1182/blood.V124.21.4430.4430

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation for Primary Mediastinal B Cell Lymphoma in the Rituximab Era: A Retrospective Study By the EBMT Lymphoma Working Party

Irit Avivi, MD, Ariane Boumendil, Hervé Hervé Finel, PhD, Arnon Nagler, MD, Aïda Sousa Bothello, MD, Josep Maria Ribera Santasusana, MD, Elisabeth A. Vandenberghe, MB, PhD, Boris Afanasyev, Dominique Bordessoule, MD, José Maria Moraleda, MD, Eulogio Conde, MD PhD, David Pohlreich, Peter Dreger, MD

Blood (2014) 124 (21): 1195.

https://doi.org/10.1182/blood.V124.21.1195.1195

Published: 2014

Journal Articles

An Interactive 3D Lymphoma's Stage Calculator Assistant: A New Tool to Help Hematologists in Routine Practice

Mohamed Touati, MD, Jeremy Assenat, Jacques Monteil, MD, Philippe De Souza, MD, Magdalena Munyamahoro, Sandra Juge, Pierre-Marie Preux, MD, Arnaud Jaccard, MD, Dominique Bordessoule, MD

Blood (2014) 124 (21): 1323.

https://doi.org/10.1182/blood.V124.21.1323.1323

Published: 2014

Journal Articles

Impact of CD3+ and CD34+ Doses in the Mobilized Peripheral Blood Stem Cell Grafts on the Outcome of Reduced-Intensity Conditioning Allogenic Transplantation from Matched Unrelated Donors for Acute Myeloid Leukemia – an Analysis from the Acute Leukemia Working Party of the EBMT

Tomasz Czerw, Myriam Labopin, MD, Christoph Schmid, Jan J. Cornelissen, Patrice Chevallier, Didier Blaise, MD PhD, Jurgen H Kuball, MDPhD, Noel Milpied, MD PhD, Jean-Yves Cahn, Bruno Lioure, MD PhD, Nathalie Fegueux, MD, Laurence Clement, Anna Sandstedt, Johan Maertens, MD, Gaelle Guillerm, MD, Dominique Bordessoule, MD, Mohamad Mohty, Arnon Nagler

Blood (2014) 124 (21): 190.

https://doi.org/10.1182/blood.V124.21.190.190

Published: 2014

Journal Articles

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

Miguel Hie, Julie Gay, Lionel Galicier, François Provôt, Claire Presne, Pascale Poullin, Guy Bonmarchand, Alain Wynckel, Ygal Benhamou, Philippe Vanhille, Aude Servais, Dominique Bordessoule, Jean-Philippe Coindre, Mohamed Hamidou, Jean-Paul Vernant, Agnès Veyradier, Paul Coppo, the French Thrombotic Microangiopathies Reference Centre

Blood (2014) 124 (2): 204–210.

https://doi.org/10.1182/blood-2014-01-550244

Published: 2014

Includes: Supplemental data

Journal Articles

Arsenic Trioxide (ATO) Or ATRA For Consolidation Treatment Of Standard Risk Non Elderly Newly Diagnosed APL– Second Interim Analysis Of a Randomized Trial (APL 2006) By The French Belgian Swiss APL Group

Blood (2013) 122 (21): 495.

https://doi.org/10.1182/blood.V122.21.495.495

Published: 2013

Journal Articles

The Role Of High Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT) In Patients With POEMS Syndrome: A Retrospective study Of The Plasma Cell Disorders Subcommittee Of The Chronic Malignancy Working Party Of The EBMT

Gordon Cook, MD, PhD, Laurent Garderet, MD, Simona Iacobelli, Ph. D, Curly Morris, MD, Nikolaus Kroeger, MD, Anja van Biezen, StatAnalyst, M Rovira, Jenny Byrne, Dominique Bordessoule, Giuseppe Leone, M.D., Arnon Nagler, MD, Mark Cook, Laurence Legros, MD, PhD, Gert J. Ossenkoppele, R Gacria Sanz, Jennifer Hoek, Luca Castagna, MD

Blood (2013) 122 (21): 415.

https://doi.org/10.1182/blood.V122.21.415.415

Published: 2013

Journal Articles

Safety and Efficacy Of Rituximab In adult’s Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux Registry

Blood (2013) 122 (21): 450.

https://doi.org/10.1182/blood.V122.21.450.450

Published: 2013

Journal Articles

Preemptive Rituximab Infusions Efficiently Prevent Relapses In Acquired Thrombotic Thrombocytopenic Purpura. Experience Of The French Thrombotic Microangiopathies Reference Center

Miguel HIE, MD, Julie Gay, MD, Lionel Galicier, MD, Francois Provot, Sandrine Malot, Pascale Poullin, MD, Guy Bonmarchand, MD, Alain Wynckel, MD, Ygal Benhamou, MD, Philippe Vanhille, Dominique Bordessoule, MD, PhD, Jean-Paul Vernant, Agnes Veyradier, MD PhD, Paul Coppo, MD PhD

Blood (2013) 122 (21): 448.

https://doi.org/10.1182/blood.V122.21.448.448

Published: 2013

Journal Articles

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

Norbert Vey, Jean-Henri Bourhis, Nicolas Boissel, Dominique Bordessoule, Thomas Prebet, Aude Charbonnier, Anne Etienne, Pascale Andre, François Romagne, Don Benson, Herve Dombret, Daniel Olive

Blood (2012) 120 (22): 4317–4323.

https://doi.org/10.1182/blood-2012-06-437558

Published: 2012

Includes: Supplemental data

NARROW

A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial

Incidence and Prevalence of Light Chain Amyloidosis: A Population-Based Study

Efficacy of Eculizumab in Gemcitabine-Induced Thrombotic Microangiopathy: Experience of the French Thrombotic Microangiopathies Reference Centre

Thrombotic Thrombocytopenic Purpura Misdiagnosed As Autoimmune Cytopenia: Causes of Diagnostic Errors and Consequence on Outcome. Experience of the French Thrombotic Microangiopathies Reference Centre

Is Arsenic Trioxide (ATO) Required in the Treatment of High Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL2006) By the French Belgian Swiss APL Group

Arsenic Trioxide (ATO) and ATRA with Limited Chemotherapy (CT) in Newly Diagnosed Standard Risk APL in the Elderly. a Report By the French Belgian Swiss APL Group (APL 2006 trial)

Correlation Between Bone Marrow Dysplasia and Genomic Profile in De Novo Acute Myeloid Leukemia (AML): A Study By the ALFA Group

Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group

Very Good Response and Overall Survival after Allogeneic Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis; Results of a Non-Interventional Study By the Plasma Cell Disorder Subcommittee of the Chronic Malignancy Working Party of the EBMT

Outcome of Lower Risk Non Del 5q MDS after Failure of Erythropoiesis Stimulating Agents (ESA), and Impact of Post-ESA Treatment on Survival: A Retrospective European Study

Impact of Rituximab-Based Immunochemotherapy Induction and Maintenance on the Immunisation Rate Against Tetanus Toxin in Follicular Lymphoma Treated Patients : A Subanalysis of the PRIMA Study

Autologous Stem Cell Transplantation for Primary Mediastinal B Cell Lymphoma in the Rituximab Era: A Retrospective Study By the EBMT Lymphoma Working Party

An Interactive 3D Lymphoma's Stage Calculator Assistant: A New Tool to Help Hematologists in Routine Practice

Impact of CD3+ and CD34+ Doses in the Mobilized Peripheral Blood Stem Cell Grafts on the Outcome of Reduced-Intensity Conditioning Allogenic Transplantation from Matched Unrelated Donors for Acute Myeloid Leukemia – an Analysis from the Acute Leukemia Working Party of the EBMT

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

Arsenic Trioxide (ATO) Or ATRA For Consolidation Treatment Of Standard Risk Non Elderly Newly Diagnosed APL– Second Interim Analysis Of a Randomized Trial (APL 2006) By The French Belgian Swiss APL Group

The Role Of High Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT) In Patients With POEMS Syndrome: A Retrospective study Of The Plasma Cell Disorders Subcommittee Of The Chronic Malignancy Working Party Of The EBMT

Safety and Efficacy Of Rituximab In adult’s Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux Registry

Preemptive Rituximab Infusions Efficiently Prevent Relapses In Acquired Thrombotic Thrombocytopenic Purpura. Experience Of The French Thrombotic Microangiopathies Reference Center

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only